Anti-EGFR Antibody-Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth.
Cheung A, Chenoweth AM, Johansson A, Laddach R, Guppy N, Trendell J, Esapa B, Mavousian A, Navarro-Llinas B, Haider S, Romero-Clavijo P, Hoffmann RM, Andriollo P, Rahman KM, Jackson P, Tsoka S, Irshad S, Roxanis I, Grigoriadis A, Thurston DE, Lord CJ, Tutt ANJ, Karagiannis SN.
Cheung A, et al. Among authors: jackson p.
Clin Cancer Res. 2024 Aug 1;30(15):3298-3315. doi: 10.1158/1078-0432.CCR-23-3110.
Clin Cancer Res. 2024.
PMID: 38772416
Free PMC article.